Pharmacogenetics of tenofovir and emtricitabine penetration into cerebrospinal fluid
Background: Blood-cerebrospinal fluid (CSF) barrier transporters affect the influx and efflux of drugs. The antiretrovirals tenofovir and emtricitabine may be substrates of blood-brain barrier (BBB) and blood-CSF barrier transporters, but data are limited regarding the pharmacogenetics and pharmacok...
Saved in:
Main Authors: | Eric H. Decloedt (Author), Phumla Z. Sinxadi (Author), Lubbe Wiesner (Author), John A. Joska (Author), David W. Haas (Author), Gary Maartens (Author) |
---|---|
Format: | Book |
Published: |
AOSIS,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population
by: Aida N. Kawuma, et al.
Published: (2023) -
Cerebrospinal Fluid and Brain Tissue Penetration of Tenofovir, Lamivudine, and Efavirenz in Postmortem Tissues with Cryptococcal Meningitis
by: Melanie R. Nicol, et al.
Published: (2019) -
Weight gain on dolutegravir: Association is not the same as causation
by: Gary Maartens, et al.
Published: (2023) -
Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
by: Enkosi Mondleki, et al.
Published: (2022) -
Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice
by: Canetti D, et al.
Published: (2023)